Literature DB >> 27185735

Is there an association between hypercholesterolemia and depression? Behavioral evidence from the LDLr(-/-) mouse experimental model.

Daiane Fátima Engel1, Jade de Oliveira1, Jadna Bogado Lopes1, Danúbia Bonfanti Santos1, Eduardo Luiz Gasnhar Moreira2, Marcelo Farina1, Ana Lúcia S Rodrigues1, Patricia de Souza Brocardo3, Andreza Fabro de Bem4.   

Abstract

Although epidemiological studies have reported an association between hypercholesterolemia and mood disorders, there is a lack of data regarding depressive-like behavior in animal models of hypercholesterolemia. To address these questions, we assessed depressive-like behavior and hippocampal and cortical monoaminergic metabolism in three-month-old, low-density lipoprotein receptor knockout (LDLr(-/-)) and C57BL/6 wild-type mice. The LDLr(-/-) mice exhibited depressive-like behavior in the sucrose preference test, splash test, and tail suspension test. Increased monoamine oxidase (MAO) A and B activity was evidenced in the hippocampus of LDLr(-/-) mice. Furthermore, to address whether or not cholesterol modulates MAO activity, we exposed SH-SY5Y human neuroblastoma cells to human isolated low-density lipoprotein (LDL). Notably, LDL increased the activity of MAO-A and stimulated the reactive species generation in vitro. These findings indicate that depressive-like behavior in hypercholesterolemic mice is accompanied by alterations in the monoaminergic metabolism, providing new evidence about the association between hypercholesterolemia and depression.
Copyright © 2016. Published by Elsevier B.V.

Entities:  

Keywords:  Depression; Hypercholesterolemia; Low-density lipoprotein receptor knockout mice (LDLr (– / –)); Monoamine oxidase

Mesh:

Substances:

Year:  2016        PMID: 27185735     DOI: 10.1016/j.bbr.2016.05.029

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  8 in total

1.  Morus nigra and its major phenolic, syringic acid, have antidepressant-like and neuroprotective effects in mice.

Authors:  Ana Paula Dalmagro; Anderson Camargo; Ana Lúcia Bertarello Zeni
Journal:  Metab Brain Dis       Date:  2017-08-18       Impact factor: 3.584

2.  Changes in regulators of lipid metabolism in the brain: a study of animal models of depression and hypothyroidism.

Authors:  Katarzyna Głombik; Jan Detka; Magdalena Kukla-Bartoszek; Alicja Maciejska; Bogusława Budziszewska
Journal:  Pharmacol Rep       Date:  2022-08-11       Impact factor: 3.919

3.  Gender-Based Differences in Anxiety and Depression Following Acute Myocardial Infarction.

Authors:  Pranas Serpytis; Petras Navickas; Laura Lukaviciute; Alvydas Navickas; Ramunas Aranauskas; Rokas Serpytis; Ausra Deksnyte; Sigita Glaveckaite; Zaneta Petrulioniene; Robertas Samalavicius
Journal:  Arq Bras Cardiol       Date:  2018-08-23       Impact factor: 2.000

4.  Impaired adult hippocampal neurogenesis in a mouse model of familial hypercholesterolemia: A role for the LDL receptor and cholesterol metabolism in adult neural precursor cells.

Authors:  Daiane F Engel; Anna N Grzyb; Jade de Oliveira; Alexandra Pötzsch; Tara L Walker; Patricia S Brocardo; Gerd Kempermann; Andreza F de Bem
Journal:  Mol Metab       Date:  2019-09-11       Impact factor: 7.422

Review 5.  Are Lipids Possible Markers of Suicide Behaviors?

Authors:  Agnieszka Kułak-Bejda; Grzegorz Bejda; Magdalena Lech; Napoleon Waszkiewicz
Journal:  J Clin Med       Date:  2021-01-18       Impact factor: 4.241

6.  Structural insights into GIRK2 channel modulation by cholesterol and PIP2.

Authors:  Yamuna Kalyani Mathiharan; Ian W Glaaser; Yulin Zhao; Michael J Robertson; Georgios Skiniotis; Paul A Slesinger
Journal:  Cell Rep       Date:  2021-08-24       Impact factor: 9.423

7.  Hypocholesterolemia is an independent risk factor for depression disorder and suicide attempt in Northern Mexican population.

Authors:  Marcela Segoviano-Mendoza; Manuel Cárdenas-de la Cruz; José Salas-Pacheco; Fernando Vázquez-Alaniz; Osmel La Llave-León; Francisco Castellanos-Juárez; Jazmín Méndez-Hernández; Marcelo Barraza-Salas; Ernesto Miranda-Morales; Oscar Arias-Carrión; Edna Méndez-Hernández
Journal:  BMC Psychiatry       Date:  2018-01-15       Impact factor: 3.630

8.  Factors Associated with the Risk of Developing Coronary Artery Disease in Medicated Patients with Major Depressive Disorder.

Authors:  Roger C M Ho; Anna C Chua; Bach X Tran; Carol C Choo; Syeda Fabeha Husain; Giang T Vu; Roger S McIntyre; Cyrus S H Ho
Journal:  Int J Environ Res Public Health       Date:  2018-09-21       Impact factor: 3.390

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.